EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Oncogenic microRNA-1290 and SCAI Gene as Potential Biomarker for Colorectal Carcinoma

Rashida Naseem, Samiah Shahid iD, Wajeehah Shahid, Ghulam Abbas

Technology in Cancer Research & Treatment · 2024

DOI: 10.1177/15330338241286283 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Technology in Cancer Research & Treatment, 2024. Verfasst von Rashida Naseem und 3 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Molecular Biology and Biotechnology, The University of Lahore, Lahore, Pakistan. Hauptthemen laut MEDLINE: MicroRNAs, Colorectal Neoplasms, Biomarkers, Tumor, Gene Expression Regulation, Neoplastic. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Colorectal cancer (CRC) is the world's third most frequent cancer, with a significant mortality rate due to late detection. There is a need to search for biomarkers that can detect colorectal cancer at an early stage. MicroRNAs (miRNAs) regulate several targets that function as oncogenes and/or tumor suppressor genes, so any change in microRNA expression level can predict abnormality.

Objective

The objective of the study was to evaluate the expression of miR-1290, and Suppressor of cancer cell invasion ( SCAI) gene that may be used as biomarkers for early diagnosis of colorectal carcinoma. Methodology This study included 50 subjects consisting of newly diagnosed colorectal carcinoma patients ( n = 25), and healthy controls ( n = 25). After RNA isolation and reverse transcription, the expression level of miR-1290 and SCAI gene in the tissues and plasma samples of CRC patients were analyzed using real time PCR and compared with healthy individuals as normal controls. The 2 −ΔΔCt formula was used to compute the fold-change, while using miR-16 and GAPDH as reference genes for normalization.

Results

We found that miR-1290 is upregulated, whereas SCAI gene is downregulated in both plasma and tissue samples of CRC patients. For miR-1290, the sensitivity was 96% and specificity was 100%, and for SCAI, 100% sensitivity and 88% specificity was calculated by ROC analysis.

Conclusion

The expression of miR-1290 and SCAI gene may be utilized as biomarkers for diagnosis of colorectal carcinoma.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsColorectal NeoplasmsBiomarkers, TumorGene Expression Regulation, NeoplasticHumansFemaleMaleMiddle AgedROC CurveAgedCase-Control StudiesAdultNeoplasm Staging

Stichwörter der Autor:innen

carcinomacolorectal cancergene expressionmiRsuppressor of cancer cell invasion

Substanzen

MicroRNAsBiomarkers, TumorMIRN1290 microRNA, human

Autor:innen und Institutionen

  • Institute of Molecular Biology and Biotechnology, The University of Lahore, Lahore, Pakistan.
  • Research Centre for Health Sciences, The University of Lahore, Lahore, Pakistan.
  • Department of Physics, The University of Lahore, Lahore, Pakistan.
  • Department of Gastroenterology, Allama Iqbal Medical college, Lahore, Pakistan.

ORCID-Profile: Samiah Shahid

Zitieren

APA

Naseem, R., Shahid, S., Shahid, W., & Abbas, G. (2024). Oncogenic microRNA-1290 and SCAI Gene as Potential Biomarker for Colorectal Carcinoma. Technology in Cancer Research & Treatment. https://doi.org/10.1177/15330338241286283

Vancouver

Naseem R, Shahid S, Shahid W, Abbas G. Oncogenic microRNA-1290 and SCAI Gene as Potential Biomarker for Colorectal Carcinoma. Technology in Cancer Research & Treatment. 2024. doi:10.1177/15330338241286283

BibTeX
@article{Naseem2024,
  author = {Naseem, Rashida and Shahid, Samiah and Shahid, Wajeehah and Abbas, Ghulam},
  title = {Oncogenic microRNA-1290 and SCAI Gene as Potential Biomarker for Colorectal Carcinoma},
  journal = {Technology in Cancer Research & Treatment},
  year = {2024},
  doi = {10.1177/15330338241286283}
}
Kostenlos starten →